The introduction of reliable techniques for the measurement of serum levels of vitamin B12 and folate has meant that megaloblastic anaemias can be more readily classified as being due to deficiency of one or occasionally both of these substances. The excretion of formiminoglutamic acid (figlu) in the urine of patients with folic-acid deficiency has further aided this differentiation. However, unless these tests clearly indicate deficiency of one substance with normal levels of the other, differentiation is often not precise. It has been shown that in vitamin-B12 deficiency serum-folate levels can be low, normal, or raised (Hansen and Weinfeld, 1962) , and in folic-acid deficiency the vitamin-B12 level may be normal or reduced (Johnson et al., 1962 . Figlu excretion may also occur in patients with vitamin-B12 deficiency (Chanarin et al., 1962) . There would therefore seem to be a place for the use of a therapeutic trial of vitamin B12 or folic acid as a further aid in the differentiation of megaloblastic anaemia provided a " physiological" dosage is given. Oral administration of folic acid in small doses would appear to be the easiest way of attempting such an investigation. Folic-acid deficiency, apart from that occurring in the malabsorption syndrome, has been infrequently recognized in the past, and a significant response to small doses of folic acid would provide good evidence of such a deficiency. Reports of the value of small doses of folic acid in the differentiation of the cause of megaloblastic anaemia have appeared in the literature (Marshall and Jandl, 1960; Hansen and Weinfeld, 1962) , but the methods and dosages employed have varied, so that a standard procedure has not been established. This paper describes the effect of the administration of small (200 [kg. daily) oral doses of folic acid in a group of patients with megaloblastic anaemia.
Patients Studied
Thirty patients with megaloblastic anaemia were studied. In each case the diagnosis was confirmed by examination of the sternal marrow. On the basis of the history, measurement of serum-vitamin-B12 and serum-folate levels, figlu excretion, and with the aid of supporting tests such as the maximal histamine test meal (Kay, 1953) , peroral small-bowel biopsy (Read et al., 1962) , and dietary history, the patients were further classified as follows:
Vitamin-B 2 Deficiency (Table I ).-Thirteen patients were studied. The cause of the deficiency in Cases 1-12 was Addisonian pernicious anaemia and in Case 13 ileal resection following Crohn's disease.
Post-gastrectomy Group (Table II ).-Nine patients had megaloblastic anaemia after partial or total gastrectomy. Cases 19 and 20 had total resections, the remainder partial.
Malabsorption Syndrome (Table II) (Gough et al., 1963) , and one was a man who had excluded green vegetables in his diet in order to control chronic diarrhoea. After an initial assessment of haemoglobin and packed-cell volume, all patients were placed on a " white diet "-that is, containing no red meat or offal and low in vegetables containing folic acid. This diet has been calculated to contain 15 Mtg. of folic acid and less than 0.5 jug. of vitamin B12 per day (McCance and Widdowson, 1960 Dacie (1956) .
Reticulocyte counts were performed on blood suspended in 1% new methylene blue (normal figures for this method 0.2-2 %). Patients were defined as showing a reticulocyte response if the count exceeded 4 % on one or more occasions.
Serum-vitamin-B12 levels were measured by microbiological assay using Lactobacillus leichmanii (Matthews, 1962) (normal range 140-900 ujpg./ml.).
Serum-folate levels were measured by microbiological assay with Lactobacillus casei ATCC 7469 (Waters and Mollin, 1961) (normal range 5.9-21 mpug./ml.) In megaloblastic anaemia due to deficiency of folic acid, serum-folate levels are usually <4 mlig./ml. Urinary Figlu. Patients were given an oral loading dose of 15 g. of histidine, and urinary figlu was detected by conventional voltage electrophoresis on cellulose acetate strips (Kohn et al., 1961) . The method is not strictly quantitative, but a rough grading of the " figlu spot'" was made as +, + +, + + +, where the + + + spot was equivalent to a urinary figlu concentration of more than 500 ptg./ml.
Results
Vitamin-B12 Deficiency (Table I) A reticulocyte response occurred in only three patients (Cases 9, 10, and 12), the maximal reticulocyte counts being 4.2%, 6.4%, and 6.1%. At the end of 10 days' study the haemoglobin concentrations had increased 4%, 4%, and 8% respectively. Reticulocyte levels in other patients reached values of 1.0-3.9%, and in no case was there an increase in haemoglobin concentration greater than 4%. In five patients haemoglobin levels fell slightly during the study. Maximal reticulocyte counts in all patients who responded occurred on the 10th or 11th day, and further prolongation of therapy did not produce a further rise in haemoglobin concentration. The patients showing this response did not seem to differ clinically from the " non-responders." The excretion of figlu was no greater than in those showing a response, and serum-folate levels were within normal levels in two patients. Initial vitamin-B12 levels were not significantly different, neither was the haemoglobin concentration. Vitamin-B12 levels in two patients were not significantly changed after the 10-day course of folic acid. In one patient (Case 9) there was a significant rise in the serumvitamin-B12 level after treatment. In other patients without a reticulocyte response there was no change in vitamin-Bl1 levels before and after folic-acid therapy. In all patients showing a reticulocyte response the marrow after treatment was unchanged. A full haematological response (reticulocyte counts, 5.2-39%) was seen in all patients after vitamin-B,2 therapy.
Post-gastrectomy Group (Table II) In seven of the nine patients a reticulocyte response was seen, varying from 6.0 to 13%. The maximal response occurred in five patients during the 11th to 13th day, and in two others it occurred earlier (Cases 14 and 21). In these seven patients a rise in haemoglobin concentration occurred within 10 days, ranging from 4 to 16%, and the haemoglobin eventually reached normal levels in five patients on continued therapy with small doses of folic acid. These seven patients all had biochemical evidence of folic-acid deficiency-that is, four patients had serum-folate levels below 2 m~ug./ml. and in the other three the levels were between 4 and 5 m.tg./ml. In five of the seven the urinary excretion of figlu was increased, but in the other two it was not possible to complete the test. The initial serumvitamin-BI2 levels of six of these seven patients who responded to the small doses of folic acid were below the normal range before the folic-acid therapy, but rose to normal levels on folic acid alone in three patients (Cases 14, 16, and 17 of these patients had previously undergone total gastrectomy, and it was concluded that they had a combined deficiency of vitamin B12 and folic acid.
Two patients (Cases 15 and 22) showed no response to the small doses of folic acid and were apparently suffering from a deficiency of vitamin B12 alone. The serum-vitamin-B12 levels of these patients were initially subnormal (110 and 115 tlg./ml. respectively) and showed no significant increase after folic-acid therapy.
Malabsorption Group (Table II) Each of these four patients had malabsorption due to adult coeliac disease and all showed steatorrhoea (fat excretion >6 g./day on 100-g. fat load). None of these patients showed a reticulocyte response despite the low levels of serum folate in all four and the strongly positive figlu tests. In one patient (Case 26) a slight rise of haemoglobin (5%) occurred, but in the others the levels remained unchanged. In Case 26 the vitamin-B12 level rose significantly, but in the other three it remained substantially unchanged. The bone-marrow remained megaloblastic in all four patients, but a full haematological response followed massive doses of folic acid and iron supplants.
Nutritional Group (Table II) There were four patients in this group, all of whom showed a reticulocyte response varying from 10 to 25%. The maximum response occurred in three patients on the 12th day and in the fourth on the 7th day. All four showed a slight rise in the haemoglobin ranging from 4 to 7%, and in three the serum-vitamin-B12 level rose. In Cases 27 and 29 the vitamin-B12 levels before therapy were in the range seen with megaloblastic anaemia due to vitamin-B12 deficiency but rose to normal levels on folic acid alone. On continued treatment with 200 jug. of folic acid daily full haematological remissions were obtained in all four patients.
In all patients in this group the serum-folate levels were 2 mjlg. or less and the figlu excretion test was strongly positive (+ + +). Further bone-marrow examinations were performed on two patients after the 10 days of folic-acid therapy and erythropoiesis had reverted to normal in both cases.
Discussion
It has been shown that large doses of either folic acid or vitamin B12 may produce a haematological response in patients with megaloblastic anaemia due to single or combined deficiency of either vitamin (Will et al., 1959 ; Zalusky et al., 1962) . Furthermore, large doses of folic acid in patients with vitamin-B,2 deficiency may precipitate neurological damage (Ross et al., 1948) . For the purpose of a therapeutic trial a dose of folic acid must be chosen that will not induce a remission in megaloblastic anaemia due to vitamin-B12 deficiency and, furthermore, which will not mask a subsequent response to small doses of vitamin B12' The dose of folic acid used in this study has fulfilled these criteria. The diet administered to all patients in this study was calculated to contain only 15 jig. of folic acid and less than 0.5 jig. of vitamin B12, so that any reticulocyte response could be confidently attributed to the therapy and not the diet. The effect of this diet alone was previously assessed in patients with megaloblastic anaemia and no haematological response was obtained (Gough and Read, unpublished observations, 1961) . Our criteria for accepting a therapeutic response to folic acid as final proof of folic-acid deficiency was a reticulocyte response greater than 4 %.
BRnmis MEDICAL JOURNAL
The patients with megaloblastic anaemia due to nutritional deficiency of folic acid all responded to the small dose of folic acid. A full haematological remission was obtained in all patients when the therapy was continued beyond the 10-day period of treatment. The trial was of particular diagnostic value in Cases 27 and 29 since the serum-vitamin-B12 levels before the trial began were subnormal and in the range seen in megaloblastic anaemia due to deficiency of vitamin B12' A mistaken diagnosis of pernicious anaemia might well have been made, particularly since both patients also had histamine- fast achlorhydria. While taking an improved diet, however, both patients showed a complete haematological remission on the small doses of folic acid alone, and the serum levels of vitamin B12 rose to normal and have been maintained within the normal range.
Seven of the nine patients with megaloblastic anaemia accompanying the post-gastrectomy state responded to the therapy. In Cases 14, 16, 17, and 18 folic-acid deficiency was thought to be responsible for the megaloblastic anaemia. The biochemical findings supported this diagnosis, since all these patients had low serum-folate levels and three excreted excess figlu. A combined deficiency of vitamin B,2 and folic acid was diagnosed in three patients (Cases 19, 20, and 21) , two of whom (Cases 19 and 20) had previously undergone total gastrectomy. Vitamin-B12 deficiency alone was present in Cases 15 and 22. The therapeutic trial of small doses of folic acid was of special assistance in reaching a complete diagnosis in Cases 19 and 20. Folic-acid deficiency after gastrectomy is to be more fully discussed in a later communication (Read, Gough, Mollin, and Thirkettle, in preparation) .
In the group of patients with malabsorption due to adult coeliac disease there was no response to the therapy, although they all showed biochemical evidence of folic-acid deficiency. The lack of response is presumably due to malabsorption. The use of a similar dose of folic acid (200 pug.) administered by intramuscular injections was shown to produce a full haematological remission in one patient (Case 23), and large oral doses (15 mg./day) produced a full response in the remaining three patients.
Of the 13 cases with vitamin-B12 deficiency, three (Cases 9, 10, and 12) showed a reticulocyte response according to the criteria previously defined. These patients, however, produced a further and greater response to vitamin B12 by injection. Similar findings have also been recorded by Hansen and Weinfeld (1962) . In Case 9 there was biochemical evidence of folic-acid deficiency and a response was not unexpected. Two patients showed no biochemical evidence of folic-acid deficiency as defined earlier, and the reason for their partial response to folic acid is obscure, but presumably folic-acid deficiency was present. The other 10 patients showed no response to the folic-acid therapy and all subsequently responded significantly to vitamin B12 by injection. In addition to the reticulocyte increase as an indication of a response to the folic-acid therapy there was often a slight rise in the haemoglobin concentration at the end of the 10-day period. Although the increases were small, and probably within the range of experimental error of the method, such rises were not observed in the " non-responders." Furthermore, the rate of increase in haemoglobin was maintained in the " responders " so that a normal haemoglobin concentration ultimately resulted. In addition to a reticulocyte increase and a rise in haemoglobin concentration as indications of a response to small doses of folic acid, the rise in serum-vitamin-B12 levels after treatment have provided additional evidence. It has previously been shown (Johnson et al., 1962) tl:at the serum-vitamin-B12 level of patients deficient in folic aci&rlhes on treatment with folic acid alone. Such a rise has been observed in most of our folic-acid deficient patients in this study, and this rise has been of clinical importance in preventing possible diagnostic errors of vitamin-B12 deficiency. In contrast to the findings of Johnson et al. (1962) , the serum-vitamin-B12 levels of our patients remained within the normal range and did not subsequently fall.
In our experience a therapeutic trial of small doses of folic acid has yielded information of practical value in the management of patients with megaloblastic anaemia. With the reservation that patients with the malabsorption syndrome will not respond to small oral doses of folic acid, all patients with folicacid deficiency responded to small doses. Such a response may be of clinical importance, since in addition to preventing diagnostic errors it is of value in the diagnosis and management of patients with combined deficiencies of vitamin B12 and folic acid. This is illustrated in the present study by two patients with post-gastrectomy megaloblastic anaemia, who were shown by this technique to have both vitamin-B12 and folic-acid deficiency. Therapeutic trials may also be of value when facilities were unavailable for the assay of vitamin B12 and folic acid, but it cannot be emphasized too strongly that the dosage chosen must be in the physiological range, in order that neurological complications may be avoided when vitamin-B12 deficiency is present, and that a subsequent response to small doses of vitamin B12 is not masked.
Summary
Thirty patients with megaloblastic anaemia were given a therapeutic trial of small oral doses of folic acid. They fell into four clinical groups: (1) vitamin-B12 deficiency due to Addisonian pernicious anaemia or following ileal resection; (2) post-gastrectomy anaemia, due either to vitamin-B12 or folic-acid deficiency or to combined deficiency; (3) nutritional folic-acid deficiency; and (4) malabsorption syndrome due to adult coeliac disease.
With the exception of patients with malabsorption, patients with folic-acid deficiency as the cause of the megaloblastic anaemia showed a significant reticulocyte response with a rise in haemoglobin concentration and serum-vitamin-B12 level where this was initially reduced.
Two patients with vitamin-B12 deficiency due to pernicious anaemia also responded submaximally to the folic acid, although they showed no biochemical evidence of folic-acid deficiency.
It is suggested that there is a place for such a therapeutic trial in the diagnosis of some patients with megaloblastic anaemia.
